Event Overview

COVID-19 vaccine development depends on identifying potent neutralizing antibodies. Recent research studies suggest that neutralizing antibodies found in the blood of recovered COVID-19 patients decay rapidly and the level of antibody protection may correlate with infection severity. In this webinar brought to you by The Scientist, scientists studying the SARS-CoV-2 immune response will discuss their research on SARS-CoV-2 antibody persistence and immune memory in recovered COVID-19 patients and the implications for protective immunity. 

Topics to be covered

· Assessing antibodies to SARS-CoV-2 in the saliva of COVID-19 patients

· Examining immune memory formation and persistence in individuals that recovered from mild COVID-19

Meet the Speakers:

  Jennifer Gommerman, PhD
Professor, Department of Immunology
Canada Research Chair in Tissue Specific Immunity
Associate Chair, Graduate Studies, Department of Immunology
University of Toronto

  Marion Pepper, PhD
Associate Professor, Department of Immunology
University of Washington